IA
IMVT icon

IFP Advisors’s Immunovant IMVT Stock Holding History

IFP Advisors’s Portfolio IMVT Stock Details IMVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$231 Hold
6
– – ﹤0.01% 4836
2026
Q1 		$149 Hold
6
– – ﹤0.01% 4669
2025
Q4 		$153 Hold
6
– – ﹤0.01% 4519
2025
Q3 		$97 Buy
+6
New +$97 ﹤0.01% 4546
2025
Q2 		– Hold
0
– – – 3402
2025
Q1 		– Hold
0
– – – 3775
2024
Q4 		– Hold
0
– – – 3755
2022
Q4 		– Sell
-10
Closed -$1K – 4709
2022
Q3 		$1K Hold
10
– – ﹤0.01% 4584
2022
Q2 		$1K Hold
10
– – ﹤0.01% 4357
2022
Q1 		$1K Buy
+10
New +$62 ﹤0.01% 4356

Other funds holding IMVT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

IFP Advisors's IMVT Position: Q2 2026 in Review

IFP Advisors held its Immunovant (IMVT) position steady in Q2 2026 at 6 shares worth $231. The position accounts for ﹤0.01% of the portfolio, ranked #4836.

IFP Advisors first reported a position in IMVT in Q1 2022 and has held it in 7 quarters since. The position peaked at $1K in Q3 2022. 226 funds tracked by Wall St. Rank hold IMVT as of Q2 2026.

  • IFP Advisors held 6 shares of Immunovant worth $231 as of Q2 2026.
  • IFP Advisors left its Immunovant share count unchanged in Q2 2026.
  • Immunovant made up ﹤0.01% of IFP Advisors's portfolio in Q2 2026, its #4836 holding.
  • IFP Advisors first reported a position in Immunovant in Q1 2022 and has held it in 7 quarters since.
  • IFP Advisors's Immunovant position peaked at $1K in Q3 2022.
  • 226 funds tracked by Wall St. Rank held Immunovant as of Q2 2026.

Based on IFP Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.